From: The size of the treatment effect: do patients and proxies agree?
Patients | Proxy respondents | |
---|---|---|
Total (n) | 42 | 42 |
Female (n) | 22 | 22 |
Age (years)* | 45.7 (9.7) | 47.7 (10.3) |
Years since MS onset* | 10.5 (6.1) | |
Type of MS (n) | ||
Relapsing remitting | 26 | |
Secondary progressive | 10 | |
Primary progressive | 6 | |
EDSS baseline ** | 4.8 (2.5 – 8.0) | |
EDSS after treatment** | 4.3 (1.0 – 8.0) |